Top news of the week: 10.03.2020.
#coronavirus #COVID19 #COVIDー19 #InternationalWomensDay #IWD2020 #mapoli #ASCO20 #AACR20 #ACC2020 #acc20
Startups
RT @statnews: Scientists are trying to turn blood plasma into a treatment for the disease caused by the new #coronavirus. @matthewherper explains: https://t.co/kOCkoeKS4B
OpenHow blood plasma from recovered patients could help treat the new coronavirus
The approach is based on the idea that antibodies developed by recovered patients might strengthen the immune system of new patients.
RT @RebeccaDRobbins: I added a few more medical meeting cancellations to
@statnews' running list: #Endo2020, #aaaai20, #acc20. The list is increasingly feeling like just a catalog of all the conferences scheduled for March.
https://t.co/GIcbUmF4cV
OpenSTAT’s guide to health care conferences disrupted by the coronavirus crisis
As the novel coronavirus races around the globe, a growing number of conferences are being canceled, postoponed, or put online. We're tracking them.
RT @lisamjarvis: How has CRISPR changed Jennifer Doudna's life? I spent a day w/the gene-editing pioneer (& this week's @cenmag guest editor!) to see how she's evolved as a leader, mentor, and entrepreneur. #InternationalWomensDay #IWD2020 https://t.co/fKSTsNjXnV
OpenA day with Jennifer Doudna: Trying to keep up with one of the world’s most sought-after scientists
The gene-editing tool CRISPR-Cas9 rerouted Doudna’s career path. What hasn’t changed for the renowned scientist and serial entrepreneur? Living and breathing the science
STAT's @sheridan_kate has more details on today's Biogen news: senior management incl CEO, CFO,& CMO/EVP R&D also attended the meeting at the Long Wharf hotel last week where 8 other Biogen employees may have been infected. https://t.co/0iStFtpoQB
OpenTop Biogen execs were present at meeting where attendees had Covid-19
Biogen’s CEO and other top leaders were among those at a corporate meeting attended by eight people who later tested positive for coronavirus.
RT @BobCoughlin: How the Greater Boston biomedical community is tackling the coronavirus https://t.co/QPelA9jdQS via @BostonGlobe @MassBio #coronavirus #mapoli #COVIDー19
OpenHow the Greater Boston biomedical community is tackling the coronavirus
At a historic meeting held Monday at Harvard Medical School, more than 80 clinicians and scientists came together to commit to a response.
RT @cathyarnst: Good to hear from a voice we can trust. @SusanDesmondH15 on why we should be cautious, but not panic. Thanks @matthewherper https://t.co/ghCCx5WAUY via @statnews
OpenSusan Desmond-Hellmann: The coronavirus is alarming. Here’s why you should not panic
The former Genentech executive and CEO of the Bill and Melinda Gates Foundation brings a unique perspective at a time of great unease.
Akouos nabs meaty $105M raise, adds VC and biotech veterans to board https://t.co/XLgJZvXulH https://t.co/YFXaWbetpt
OpenAkouos nabs meaty $105M raise, adds VC and biotech veterans to board
Boston-based hearing loss gene therapy biotech Akouos has grabbed a $105 million series B funding round.
That was fast: 3 months after uncloaking, Zentalis guns for IPO https://t.co/jXQM8ozWI8 https://t.co/rM13RNYZ0x
OpenThat was fast: 3 months after uncloaking, Zentalis guns for IPO
Just before Christmas, Zentalis Pharma announced itself formally to the world as a midstage cancer biotech, but with some quiet funding rounds under its belt.